Tiotropium in chronic obstructive pulmonary disease [1]

New England Journal of Medicine

Volumn 360, Issue 2, 2009, Pages 185-187

  Pedone, Claudio ^a   Incalzi, Raffaele Antonelli ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TIOTROPIUM BROMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; SCOPOLAMINE DERIVATIVE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; RATING SCALE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; OUTCOME ASSESSMENT; DRUG COMBINATION; EPIDEMIOLOGY; KIDNEY FAILURE; NOTE; DRUG EFFECT; METHODOLOGY; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG THERAPY, COMBINATION; HUMANS; KIDNEY FAILURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; FORCED EXPIRATORY VOLUME; QUALITY OF LIFE; RESEARCH DESIGN; ADMINISTRATION, INHALATION;

EID: 58149394172     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc082265     Document Type: Letter

References (1)

1. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-54.